iifl-logo

Remus Pharmaceuticals Ltd Share Price

1,865
(0.11%)
Jun 18, 2025|02:55:16 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1,863
  • Day's High1,865
  • 52 Wk High2,834.75
  • Prev. Close1,862.9
  • Day's Low1,863
  • 52 Wk Low 1,785.1
  • Turnover (lac)3.73
  • P/E55.16
  • Face Value10
  • Book Value0
  • EPS33.77
  • Mkt. Cap (Cr.)1,098.86
  • Div. Yield0
View All Historical Data
No Records Found

Remus Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

1,863

Prev. Close

1,862.9

Turnover(Lac.)

3.73

Day's High

1,865

Day's Low

1,863

52 Week's High

2,834.75

52 Week's Low

1,785.1

Book Value

0

Face Value

10

Mkt Cap (₹ Cr.)

1,098.86

P/E

55.16

EPS

33.77

Divi. Yield

0

Remus Pharmaceuticals Ltd Corporate Action

29 Aug 2024

12:00 AM

AGM

Announcement Date: 29 Aug, 2024

arrow

12 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Remus Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Remus Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

18 Jun, 2025|03:13 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 70.85%

Foreign: 0.00%

Indian: 70.85%

Non-Promoter- 5.54%

Institutions: 5.54%

Non-Institutions: 23.60%

Custodian: 0.00%

Share Price

Remus Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

1.47

1.09

1

0.01

Preference Capital

0

0

0

0

Reserves

80.59

18.05

5.58

3.13

Net Worth

82.06

19.14

6.58

3.14

Minority Interest

View Balance Sheet

No Record Found

View Profit & Loss

No Record Found

View Cash Flow

No Record Found

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024

Gross Sales

620.36

212.94

Excise Duty

0

0

Net Sales

620.36

212.94

Other Operating Income

0

0

Other Income

4.98

2.83

Remus Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,650.2

92.373,95,614.352,000.460.977,107.14101.44

Divis Laboratories Ltd

DIVISLAB

6,538

78.561,73,532.836670.462,536561.08

Cipla Ltd

CIPLA

1,503.5

24.661,21,436.241,485.41.064,254.47397.42

Dr Reddys Laboratories Ltd

DRREDDY

1,318.8

20.581,10,068.121,200.70.615,546.3345.79

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,255.4

57.761,10,060.94740.982,385224.33

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Remus Pharmaceuticals Ltd

Management

Register Office

Registrar Office

No Record Found

Registered Office

1101 to 1103 South Tower One42,

B/H Ashok Vatika Amblibopal Rd,

Gujarat - 380054

Tel: 91-079-29999857

Website: https://www.remuspharma.com

Email: cs@remuspharma.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: www.linkintime.co.in

Email: paytm.ipo@linkintime.co.in

Summary

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by t...
Read More

Company FAQs

What is the Remus Pharmaceuticals Ltd share price today?

The Remus Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1865 today.

What is the Market Cap of Remus Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd is ₹1098.86 Cr. as of 18 Jun ‘25

What is the PE and PB ratio of Remus Pharmaceuticals Ltd?

The PE and PB ratios of Remus Pharmaceuticals Ltd is 55.16 and 4.53 as of 18 Jun ‘25

What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Remus Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Remus Pharmaceuticals Ltd is ₹1785.1 and ₹2834.75 as of 18 Jun ‘25

What is the CAGR of Remus Pharmaceuticals Ltd?

Remus Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at 60.66%, 1 Year at -9.40%, 6 Month at -22.78%, 3 Month at -6.61% and 1 Month at -12.09%.

What is the shareholding pattern of Remus Pharmaceuticals Ltd?

The shareholding pattern of Remus Pharmaceuticals Ltd is as follows:
Promoters - 70.85 %
Institutions - 5.54 %
Public - 23.60 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.